Bio Essence Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 0.14976 million compared to USD 0.181579 million a year ago. Revenue was USD 0.341329 million compared to USD 0.306414 million a year ago.

Net loss was USD 0.178836 million compared to USD 0.23312 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.